Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term adverse effects. Found 220 abstracts

no pagination
Balamucki CJ, DeJesus R, Galloway TJ, Mancuso AA, Amdur RJ, Morris CG, Kirwan JM, Mendenhall WM. Impact of radiographic findings on for prognosis skin cancer with perineural invasion. Am J Clin Oncol. 2015 Jun;38(3):248-51.
Borghaei H, Paz-Ares L, Horn L, Spigel DR, Steins M, Ready NE, Chow LQ, Vokes EE, Felip E, Holgado E, Barlesi F, Kohlhaufl M, Arrieta O, Burgio MA, Fayette J, Lena H, Poddubskaya E, Gerber DE, Gettinger SN, Rudin CM, Rizvi N, Crino L, Blumenschein GR, Antonia SJ, Dorange C, Harbison CT, Graf Finckenstein F, Brahmer JR. Nivolumab versus Docetaxel in Advanced Nonsquamous Non-Small-Cell Lung Cancer. The New England journal of medicine. 2015 Oct 22;373(17):1627-39.
Cheung M, Kadariya Y, Pei J, Talarchek J, Facciolo F, Visca P, Righi L, Cozzi I, Testa JR, Ascoli V. An asbestos-exposed family with multiple cases of pleural malignant mesothelioma without inheritance of a predisposing BAP1 mutation. Cancer Genet. 2015 Oct;208(10):502-7.   PMCID: PMC4608746
Coleman RL, Sill MW, Bell-McGuinn K, Aghajanian C, Gray HJ, Tewari KS, Rubin SC, Rutherford TJ, Chan JK, Chen A, Swisher EM. A phase II evaluation of the potent, highly selective PARP inhibitor veliparib in the treatment of persistent or recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer in patients who carry a germline BRCA1 or BRCA2 mutation - An NRG Oncology/Gynecologic Oncology Group study. Gynecol Oncol. 2015 Jun;137(3):386-91.   PMCID: 4447525
Corr BR, Winter AM, Sammel MD, Chu CS, Gage BF, Hagemann AR. Effectiveness and safety of expanded perioperative thromboprophylaxis in complex gynecologic surgery. Gynecol Oncol. 2015 Sep;138(3):501-6.   PMCID: 4736717
Dai X, Zhao Y, Liang Z, Dassarath M, Wang L, Jin L, Chen L, Dong J, Price RA, Ma CM. Volumetric-modulated arc therapy for oropharyngeal carcinoma: a dosimetric and delivery efficiency comparison with static-field IMRT. Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics (AIFB). 2015 Feb;31(1):54-9.   PMCID: PMC4282814
Galloway TJ, Wirth LJ, Colevas AD, Gilbert J, Bauman JE, Saba NF, Raben D, Mehra R, Ma AW, Atoyan R, Wang J, Burtness B, Jimeno A. A Phase I Study of CUDC-101, a Multitarget Inhibitor of HDACs, EGFR, and HER2, in Combination with Chemoradiation in Patients with Head and Neck Squamous Cell Carcinoma. Clin Cancer Res. 2015 Apr;21(7):1566-73.
Hochster HS, Uboha N, Messersmith W, Gold PJ, O Neil BH, Cohen D, Denlinger C, Cohen S, Leichman CG, Leichman L, Lenz HJ. Phase II study of selumetinib (AZD6244, ARRY-142886) plus irinotecan as second-line therapy in patients with K-RAS mutated colorectal cancer. Cancer Chemother Pharmacol. 2015 Jan;75(1):17-23.
Kelly JL, Salles G, Goldman B, Fisher RI, Brice P, Press O, Casasnovas O, Maloney DG, Soubeyran P, Rimsza L, Haioun C, Xerri L, LeBlanc M, Tilly H, Friedberg JW. Low Serum Vitamin D Levels Are Associated With Inferior Survival in Follicular Lymphoma: A Prospective Evaluation in SWOG and LYSA Studies. J Clin Oncol. 2015 May;33(13):1482-90.   PMCID: PMC4404425
Lee EQ, Kaley TJ, Duda DG, Schiff D, Lassman AB, Wong ET, Mikkelsen T, Purow BW, Muzikansky A, Ancukiewicz M, Huse JT, Ramkissoon S, Drappatz J, Norden AD, Beroukhim R, Weiss SE, Alexander BM, McCluskey CS, Gerard M, Smith KH, Jain RK, Batchelor TT, Ligon KL, Wen PY. A Multicenter, Phase II, Randomized, Noncomparative Clinical Trial of Radiation and Temozolomide with or without Vandetanib in Newly Diagnosed Glioblastoma Patients. Clin Cancer Res. 2015 Aug 15;21(16):3610-8.   PMCID: 4790106
Moore HC, Unger JM, Phillips KA, Boyle F, Hitre E, Porter D, Francis PA, Goldstein LJ, Gomez HL, Vallejos CS, Partridge AH, Dakhil SR, Garcia AA, Gralow J, Lombard JM, Forbes JF, Martino S, Barlow WE, Fabian CJ, Minasian L, Meyskens FL, Gelber RD, Hortobagyi GN, Albain KS. Goserelin for ovarian protection during breast-cancer adjuvant chemotherapy. The New England journal of medicine. 2015 Mar 05;372(10):923-32.   PMCID: 4405231
Motzer RJ, Escudier B, McDermott DF, George S, Hammers HJ, Srinivas S, Tykodi SS, Sosman JA, Procopio G, Plimack ER, Castellano D, Choueiri TK, Gurney H, Donskov F, Bono P, Wagstaff J, Gauler TC, Ueda T, Tomita Y, Schutz FA, Kollmannsberger C, Larkin J, Ravaud A, Simon JS, Xu LA, Waxman IM, Sharma P, CheckMate I. Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma. The New England journal of medicine. 2015 Nov 05;373(19):1803-13.
Motzer RJ, Rini BI, McDermott DF, Redman BG, Kuzel TM, Harrison MR, Vaishampayan UN, Drabkin HA, George S, Logan TF, Margolin KA, Plimack ER, Lambert AM, Waxman IM, Hammers HJ. Nivolumab for Metastatic Renal Cell Carcinoma: Results of a Randomized Phase II Trial. J Clin Oncol. 2015 May;33(13):1430-7.   PMCID: PMC4806782
Munshi T, Heckman CJ, Darlow S. Association between tobacco waterpipe smoking and head and neck conditions: A systematic review. Journal of the American Dental Association (1939). 2015 Oct;146(10):760-6.
Murphy CT, Heller S, Ruth K, Buyyounouski MK, Weinberg D, Uzzo RG, Plimack E, Kutikov A, Chen DY, Horwitz EM. Evaluating toxicity from definitive radiation therapy for prostate cancer in men with inflammatory bowel disease: Patient selection and dosimetric parameters with modern treatment techniques. Practical radiation oncology. 2015 May;5(3):e215-e222.   PMCID: Needs PMCID
Peethambaram PP, Hartmann LC, Jonker DJ, de Jonge M, Plummer ER, Martin L, Konner J, Marshall J, Goss GD, Teslenko V, Clemens PL, Cohen LJ, Ahlers CM, Alland L. A phase I pharmacokinetic and safety analysis of epothilone folate (BMS-753493), a folate receptor targeted chemotherapeutic agent in humans with advanced solid tumors. Invest New Drugs. 2015 Apr;33(2):321-31.
Prucha MG, Fisher SG, McIntosh S, Grable JC, Holderness H, Thevenet-Morrison K, de Monegro ZQ, Sanchez JJ, Bautista A, Diaz S, Ossip DJ. Health care workers' knowledge, attitudes and practices on tobacco use in economically disadvantaged dominican republic communities. International journal of environmental research and public health. 2015 Apr;12(4):4060-75.   PMCID: PMC4410233
Shah JJ, Stadtmauer EA, Abonour R, Cohen AD, Bensinger WI, Gasparetto C, Kaufman JL, Lentzsch S, Vogl DT, Gomes CL, Pascucci N, Smith DD, Orlowski RZ, Durie BG. Carfilzomib, pomalidomide, and dexamethasone for relapsed or refractory myeloma. Blood. 2015 Nov 12;126(20):2284-90.   PMCID: PMC4643003
Stabler CT, Lecht S, Lazarovici P, Lelkes PI. Mesenchymal stem cells for therapeutic applications in pulmonary medicine. British medical bulletin. 2015 Sep;115(1):45-56.
Sweeney CJ, Chen YH, Carducci M, Liu G, Jarrard DF, Eisenberger M, Wong YN, Hahn N, Kohli M, Cooney MM, Dreicer R, Vogelzang NJ, Picus J, Shevrin D, Hussain M, Garcia JA, DiPaola RS. Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer. The New England journal of medicine. 2015 Aug 20;373(8):737-46.   PMCID: 4562797
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term adverse effects

adverse effects Middle Aged Female Male drug therapy Aged Adult therapeutic use administration & dosage mortality Antineoplastic Agents 80 and over Aged pathology methods antagonists & inhibitors Disease-Free Survival Time Factors Kaplan-Meier Estimate Antineoplastic Combined Chemotherapy Protocols chemically induced therapy Monoclonal Antibodies Treatment Outcome analogs & derivatives Squamous Cell Carcinoma radiotherapy Survival Analysis Maximum Tolerated Dose etiology blood Head and Neck Neoplasms genetics Drug Dose-Response Relationship Drug Administration Schedule Prostatic Neoplasms metabolism Mutation Follow-Up Studies Disease Progression Renal Cell Carcinoma diagnosis Radiotherapy Dosage Lung Neoplasms adverse CD274 Antigens Intensity-Modulated Radiotherapy effects Kidney Neoplasms Smoking Quinazolines Cohort Studies Benzimidazoles Radiotherapy Combined Modality Therapy Proportional Hazards Models Prospective Studies Taxoids derivatives complications immunology prevention & control analogs & cancer Ovarian Neoplasms Intravenous Infusions Extended prophylaxis BRCA1 Protein Glioblastoma Proto-Oncogene Proteins cancer predisposition decellularized scaffold X-Ray Computed Tomography Folic Acid Ubiquitin Thiolesterase Liquid Chromatography Organs at Risk Pulmonary Embolism Smoking Cessation Gynecologic surgery Skin Neoplasms Volumetric-modulated arc therapy epidemiology Chemoradiotherapy Clinical Competence Oropharyngeal Neoplasms head and neck health Toxicity Pregnancy Rate Ovarian cancer Camptothecin Vitamin D Deficiency Tobacco Use Disorder surgery Cisplatin Veliparib Health Personnel radiography Hydroxamic Acids Breast Neoplasms Dominican Republic Oropharyngeal carcinoma Local Neoplasm Recurrence Fallopian Tube Neoplasms clinical applications transplantation Non-Small-Cell Lung Carcinoma Asbestos Intravenous Administration Oligonucleotide Array Sequence Analysis use Finland Canada Half-Life Magnetic Resonance Imaging Dacarbazine Gynecologic Surgical Procedures Piperidines Gastrointestinal Diseases Animal Disease Models precancerous lesions Karnofsky Performance Status Young Adult Tandem Mass Spectrometry Radiometry Bystander Effect ras Proteins Premenopause Oligopeptides Heparin drug effects Prednisone therapeutic Perioperative Period ErbB-2 Receptor Epidermal Growth Factor Receptor physiopathology flavored tobacco Italy Ulcerative Colitis Inflammatory Bowel Diseases statistics & numerical data Mouth Diseases Pedigree Combination Drug Therapy asbestos Peripheral Nerves Prognosis Adolescent Neoplasm Drug Resistance secretome
Last updated on Wednesday, February 05, 2020